Literature DB >> 14579162

Subclinical pulmonary haemorrhage causing a restrictive lung defect in three siblings with a unique urticarial vasculitis syndrome.

B M S Al Riyami1, J K Al Kaabi, E M Elagib, H S El Khatim, N J Y Woodhouse.   

Abstract

Three siblings with urticarial vasculitis syndrome (UVS) are described. All had restrictive lung function abnormalities caused by subclinical pulmonary haemorrhage. The latter was suspected after finding haemosiderin-laden macrophages and a friable bronchial mucosa during elective bronchopulmonary alveolar lavage (BAL). The chest radiographs were normal at presentation but after steroid withdrawal symptoms worsened, haemoglobin levels fell, and Case 1 developed acute pulmonary haemorrhage. This was documented by lung biopsy, which also revealed evidence of old haemorrhage and fibrosis. We concluded that these patients had a unique familial variant of UVS with a previously unreported restrictive lung disease due to subclinical pulmonary haemorrhage.

Entities:  

Mesh:

Year:  2003        PMID: 14579162     DOI: 10.1007/s10067-003-0738-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  3 in total

1.  Hypocomplementemic urticarial vasculitis (HUVS) with precocious emphysema responsive to azathioprine.

Authors:  L Breda; M Nozzi; S Harari; M Del Torto; M Lucantoni; A Scardapane; F Chiarelli
Journal:  J Clin Immunol       Date:  2013-04-25       Impact factor: 8.317

2.  Juvenile systemic lupus erythematosus and dermatomyositis associated with urticarial vasculitis syndrome: a unique presentation.

Authors:  Patrícia A Macêdo; Carolina B Garcia; Monique K Schmitz; Levi H Jales; Rosa M R Pereira; Jozélio F Carvalho
Journal:  Rheumatol Int       Date:  2010-04-17       Impact factor: 2.631

3.  A retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China.

Authors:  Hui Huang; Yan Xun Wang; Chun Guo Jiang; Jia Liu; Ji Li; Kai Xu; Zuo Jun Xu
Journal:  BMC Pulm Med       Date:  2014-01-28       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.